RΔF-SeNPs

RΔF-SeNPs are a *functionalized selenium nanoparticle* formulation, likely designed for specific targeted drug delivery or therapeutic function. Selenium nanoparticles (SeNPs) are an inorganic nanoform of selenium notable for their high biocompatibility, low toxicity, and robust antioxidant properties. Functionally, SeNPs can be engineered with targeting ligands to deliver drugs or therapeutic agents directly to diseased cells or tissues, improving bioavailability and reducing systemic toxicity. Selenium in nanoparticle form exerts pleiotropic pharmacological activities primarily via antioxidant effects, cell cycle arrest, apoptosis induction, and modulation of protein kinases and selenoproteins, with applications in cancer, neurodegenerative diseases (e.g., Alzheimer's disease, Parkinson's disease), diabetes, and inflammatory conditions. Novel SeNPs like RΔF-SeNPs may be specifically designed for enhanced targeting, therapeutic efficacy, or diagnostic capacity, but detailed mechanism or proprietary additive(s) for "RΔF" remain unclear from available literature, suggesting likely proprietary or experimental status[1][2][3][4][5].

Brand names

RΔF-SeNPs

Other names

RΔF-SeNPs